Michael Suarez

Michael Suarez

Auto-generated profile, based on publicly available information

Michael Suarez

Department of Physical Medicine and Rehabilitation Johns Hopkins University Baltimore Maryland USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Journal of Pain Research
Verified
Journal Article
Open access
DBDylan Banks
Dylan Banks
HPHannah Park
Hannah Park
WOWhitman Oehlermarx
Whitman Oehlermarx
MSMichael Suarez
Michael Suarez
MBMustafa Broachwala
Mustafa Broachwala
RRRajiv Reddy
Rajiv Reddy
In the United States, hip and knee arthroplasties are amongst the most frequently performed elective surgeries. While generally effective, a subset of patients develop chronic post-surgical pain (CPSP) in the affected joint. The management of CPSP is an incredibly important area of ongoing research, as the prevalence of individuals with arthroplasties continues to climb. Currently, there is a lack of best practice guidelines dedicated to CPSP of the hip and knee following arthroplasty. While conservative modalities including physical rehabilitation, pharmacologics, and psychological interventions remain the cornerstone of management of CPSP, this review aims to fill an important knowledge gap by providing an overview of the existing interventional treatment modalities. Procedures discussed include radiofrequency ablation (RFA), pulsed radiofrequency (PRF), peripheral nerve stimulation (PNS), spinal cord stimulation (SCS), dorsal root ganglion (DRG) stimulation, and intrathecal drug delivery systems (IDDS). Moreover, it explores other emerging therapies. To date, RFA for CPSP has the most supporting evidence, with strong support for cooled RFA. However, neuromodulation techniques including PRF, PNS, SCS and DRG stimulation each may offer promising results in treating CPSP of the hip and knee. Ultimately, without comparative analyses, the decision regarding which to pursue relies upon shared decision-making with the patient focused on tailoring treatments to the presumed underlying mechanism in line with resource availability and associated costs.

11 September 2003
Verified
Book Chapter
Closed access
MSMichael F. Suarez
Michael F. Suarez
The Cambridge Companion to Jonathan Swift - September 2003

2 February 2025 in Clinical Case Reports
Verified
Journal Article
Open access
MSMichael Suarez
Michael Suarez
DGDavid M. Gallacher
David M. Gallacher
DJDavid S. Jevotovsky
David S. Jevotovsky
HCHarman Chopra
Harman Chopra
MBMustafa Broachwala
Mustafa Broachwala
JCJoel P. Castellanos
Joel P. Castellanos
Spinal cord stimulation (SCS) is a promising therapy for the management of spinal cord injury. Following SCS, this patient experienced a significant reduction in pain and decreased spasticity, which ultimately led to improved upper extremity function.

5 August 2024 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
PDF file
DJDavid S Jevotovsky
David S Jevotovsky
MSMichael Suarez
Michael Suarez
HCHarman Chopra
Harman Chopra
BMBryan J Marascalchi
Bryan J Marascalchi
Background Intractable hiccups, defined as those persisting for over 1 month, represent a rare but significant clinical challenge often associated with substantial morbidity and refractory to standard treatments. Case presentation This case report describes the innovative use of phrenic nerve peripheral neuromodulation for managing chronic intractable hiccups in a 73-year-old male patient with a 6-year history of daily hiccups. Conventional treatments and interventional procedures had failed to provide lasting relief. Bilateral phrenic nerve peripheral nerve stimulation (PNS) placed under ultrasound guidance resulted in immediate and substantial improvement, with the patient’s Hiccup Assessment Instrument score decreasing from 6/10 to 2/10. The patient experienced significant enhancements in speech and quality of life without complications. Conclusions This novel application of phrenic nerve PNS highlights its potential as a therapeutic strategy for intractable hiccups, underscoring their pathophysiologic involvement of the diaphragm and respiratory muscles. The findings suggest that phrenic nerve PNS could offer a viable treatment option for patients unresponsive to conventional therapies, warranting further research to establish its long-term efficacy and safety.

2 February 2024 in Interventional Pain Medicine
Verified
Journal Article
Open access
HCHarman Chopra
Harman Chopra
MJMelissa Jackels
Melissa Jackels
MSMichael Suarez
Michael Suarez
PVPeter D Vu
Peter D Vu
MBMustafa Broachwala
Mustafa Broachwala
ESEellan Sivanesan
Eellan Sivanesan
Crohn's disease is a chronic inflammatory bowel condition causing symptoms, notably pain, due to ongoing intestinal inflammation or complications like abscesses, strictures, and fistulas, which are common in IBD patients. Abdominal pain affects up to 60 % of IBD patients, irrespective of disease severity, prompting medical attention. Various medications like NSAIDs , antidepressants, antispasmodics, anticonvulsants , and opioids are used to manage pain, but they have limited effectiveness and potential side effects, even during remission. In this case, a 20-year-old Caucasian female college student [height 5′4″, weight 120lbs (54.4 kg)] with juvenile idiopathic arthritis and Crohn's disease experienced severe daily abdominal pain, negatively impacting her life. Despite a multimodal regimen, including gabapentin, nortriptyline, duloxetine , and acetaminophen , her pain persisted, significantly affecting her appetite, sleep, mood, activity level, and overall quality of life (QOL). To address this, dorsal root ganglion (DRG) stimulation was considered. The patient aimed for a 20 % pain reduction and improved QOL. Trial leads were placed along the T10 and T12 DRG, resulting in a 25 % pain reduction (8–6 out of 10) and substantial QOL improvement. She could eat, sleep without interruptions, walk longer distances, and be more active. The T12 lead was more effective than the T10, targeting upper abdomen stimulation. The patient and her mother were highly satisfied and opted for permanent implantation for the T11 and T12 DRG. While DRG stimulation was approved in 2016 for chronic pain, to our knowledge, this is the first reported case of its use in a patient with debilitating Crohn's disease.

21 August 2025 in Clinical Case Reports
Verified
Journal Article
Open access
MSMichael Suarez
Michael Suarez
SSShiva Senthilkumar
Shiva Senthilkumar
MBMustafa Broachwala
Mustafa Broachwala
HCHarman Chopra
Harman Chopra
JCJeffrey Chen
Jeffrey Chen
This case highlights the potential effectiveness of posterior sacroiliac joint fusion in pain relief for patients with Bertolotti syndrome. When a patient presents with pain and lumbosacral transitional vertebrae on imaging, there should be a full evaluation for sacroiliac joint pathology, especially at the joint contralateral to the transitional vertebrae.